Cardiol Therapeutics Inc. (CRDL.TO)

CAD 1.96

(0.51%)

Revenue Summary of Cardiol Therapeutics Inc.

  • Cardiol Therapeutics Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Cardiol Therapeutics Inc.'s latest quarterly revenue in 2024 Q2 was - CAD , down 0.0% from previous quarter.
  • Cardiol Therapeutics Inc. reported a annual revenue of - CAD in annual revenue 2022, down -100.0% from previous year.
  • Cardiol Therapeutics Inc. reported a annual revenue of 78.76 Thousand CAD in annual revenue 2021, down 0.0% from previous year.
  • Cardiol Therapeutics Inc. reported a quarterly revenue of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Cardiol Therapeutics Inc. reported a quarterly revenue of - CAD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Cardiol Therapeutics Inc. (2023 - 2017)

Historical Annual Revenue of Cardiol Therapeutics Inc. (2023 - 2017)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD -100.0%
2021 78.76 Thousand CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%

Peer Revenue Comparison of Cardiol Therapeutics Inc.

Name Revenue Revenue Difference
Aurora Cannabis Inc. 270.28 Million CAD 100.0%
Avicanna Inc. 16.79 Million CAD 100.0%
Avant Brands Inc. 26.34 Million CAD 100.0%
Crescita Therapeutics Inc. 17.52 Million CAD 100.0%
Knight Therapeutics Inc. 328.19 Million CAD 100.0%
MediPharm Labs Corp. 33.06 Million CAD 100.0%
OrganiGram Holdings Inc. 149.2 Million CAD 100.0%
Canopy Growth Corporation 297.14 Million CAD 100.0%
Willow Biosciences Inc. 1.17 Million CAD 100.0%
Auxly Cannabis Group Inc. 101.07 Million CAD 100.0%